SEC Form 4 · accession 0001179110-17-013622

ABIOMED INC · ABMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Oct 30, 2017

Accepted (ET)

Nov 1, 2017 · 4:09 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000815094

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock, $0.01 par value^F3	Oct 30, 2017	M	13,500	$7.67	A	39,532	D
Common Stock, $0.01 par value^F4,F5	Oct 30, 2017	S	3,664	$178.773	D	35,868	D
Common Stock, $0.01 par value^F4,F6	Oct 30, 2017	S	2,700	$179.4864	D	33,168	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F1,F3,F2	$7.67	Oct 30, 2017	M	13,500	D	Aug 11, 2010	Aug 12, 2019	Common Stock	13,500	0	D
Stock Option (right to buy)^F1,F2	$9.99	holding	—	—	—	Aug 10, 2011	Aug 11, 2020	Common Stock	0	13,500	D

F1Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
F2This option becomes exerciseable in full on the date set forth in Table II, Column 6.
F3Exercise of stock options pursuant to reporting owner's 10b5-1 plan.
F4Sale of common stock pursuant to reporting owner's 10b5-1 plan.
F5This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $178.1700 and $179.1100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F6This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $179.170 and $179.9700. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.